93 related articles for article (PubMed ID: 8624793)
1. Synthesis and evaluation of a new bifunctional chelating agent for the preparation of radioimmunoconjugates.
Somayaji VV; Guay V; Peng Z; Sykes TR; Noujaim AA
Q J Nucl Med; 1995 Dec; 39(4):300-10. PubMed ID: 8624793
[TBL] [Abstract][Full Text] [Related]
2. Stable bifunctional chelates of metals used in radiotherapy.
Moi MK; DeNardo SJ; Meares CF
Cancer Res; 1990 Feb; 50(3 Suppl):789s-793s. PubMed ID: 2297725
[TBL] [Abstract][Full Text] [Related]
3. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
4. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.
Kukis DL; DeNardo GL; DeNardo SJ; Mirick GR; Miers LA; Greiner DP; Meares CF
Cancer Res; 1995 Feb; 55(4):878-84. PubMed ID: 7850803
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the stability and animal biodistribution of gadolinium (III) benzylamine-derivatized diethylenetriaminepentaacetic acid.
Deal KA; Motekaitis RJ; Martell AE; Welch MJ
J Med Chem; 1996 Aug; 39(16):3096-3106. PubMed ID: 8759630
[TBL] [Abstract][Full Text] [Related]
6. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.
Kozak RW; Raubitschek A; Mirzadeh S; Brechbiel MW; Junghans RP; Gansow OA; Waldmann TA
Cancer Res; 1989 May; 49(10):2639-44. PubMed ID: 2785435
[TBL] [Abstract][Full Text] [Related]
7. Preparation and protein conjugation of a divinyl sulphone derivatized bifunctional chelating agent.
Somayaji VV; Naicker SS; Sykes TR; Guay V; Noujaim AA
Cancer Biother Radiopharm; 1996 Dec; 11(6):405-14. PubMed ID: 10851501
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of labelled small peptide complexes for imaging agents with technetium-99m and biodistribution in mice.
Qi CM; Guo XF; Zhang HB; Li B; Jin W; Dai M
Yao Xue Xue Bao; 2002 Jul; 37(7):522-6. PubMed ID: 12914321
[TBL] [Abstract][Full Text] [Related]
9. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
10. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
Lewis MR; Shively JE
Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
[TBL] [Abstract][Full Text] [Related]
11. Maleimido derivatives of diethylenetriaminepentaacetic acid and triethylenetetraaminehexaacetic acid: their synthesis and potential for specific conjugation with biomolecules.
Ali MS; Quadri SM
Bioconjug Chem; 1996; 7(5):576-83. PubMed ID: 8889020
[TBL] [Abstract][Full Text] [Related]
12. Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.
Moi MK; Meares CF; McCall MJ; Cole WC; DeNardo SJ
Anal Biochem; 1985 Jul; 148(1):249-53. PubMed ID: 4037304
[TBL] [Abstract][Full Text] [Related]
13. Macrocyclic chelates of radiometals for diagnosis and therapy.
Meares CF; Moi MK; Diril H; Kukis DL; McCall MJ; Deshpande SV; DeNardo SJ; Snook D; Epenetos AA
Br J Cancer Suppl; 1990 Jul; 10():21-6. PubMed ID: 2383477
[TBL] [Abstract][Full Text] [Related]
14. Extension of the single amino acid chelate concept (SAAC) to bifunctional biotin analogues for complexation of the M(CO)3(+1) Core (M = Tc and Re): syntheses, characterization, biotinidase stability, and avidin binding.
James S; Maresca KP; Allis DG; Valliant JF; Eckelman W; Babich JW; Zubieta J
Bioconjug Chem; 2006; 17(3):579-89. PubMed ID: 16704194
[TBL] [Abstract][Full Text] [Related]
15. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
[TBL] [Abstract][Full Text] [Related]
16. Identification of important residues in metal-chelate recognition by monoclonal antibodies.
Delehanty JB; Jones RM; Bishop TC; Blake DA
Biochemistry; 2003 Dec; 42(48):14173-83. PubMed ID: 14640685
[TBL] [Abstract][Full Text] [Related]
17. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
19. Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).
Chappell LL; Rogers BE; Khazaeli MB; Mayo MS; Buchsbaum DJ; Brechbiel MW
Bioorg Med Chem; 1999 Nov; 7(11):2313-20. PubMed ID: 10632041
[TBL] [Abstract][Full Text] [Related]
20. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
J Nucl Med; 1998 Mar; 39(3):476-84. PubMed ID: 9529295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
